COVID-19 vaccination update | Israel approves plan to vaccinate West Bank laborers

Israel has come under international criticism for not sharing its vaccine stockpile with the Palestinians in the occupied West Bank and Gaza Strip, even as it plans to share surplus vaccines with far-flung allies in Africa, Europe and Latin America.

Pfizer COVID-19 vaccine reduces transmission after one dose: UK study

Researchers analysed results from thousands of COVID-19 tests carried out each week as part of hospital screenings of healthcare staff in Cambridge, eastern England.

Coronavirus | Germans clamour for COVID-19 vaccines, but shun AstraZeneca’s offering

Many people — including health workers — are skipping appointments or refusing to sign up for the AstraZeneca shot, which they fear is less effective than the Pfizer-BioNTech vaccine

US loosens Pfizer vaccine shipping regulations

The Food and Drug Administration said Thursday that it's allowing the additional option after reviewing new data from New York-based Pfizer and its German partner, BioNTech.

In a boost for battle against COVID-19, Pfizer vaccine found 94% effective in real world

Up until now, most data on the efficacy of COVID-19 vaccines has come under controlled conditions in clinical trials, leaving an element of uncertainty over how results would translate into the real world with its unpredictable variables.

Australian PM Scott Morrison gets COVID-19 vaccine in 'massive step' toward normal

Up to 4 million Australians are expected to be inoculated by March, with Morrison among a small group receiving the first round of the Pfizer/BioNTech vaccine.

Pfizer vaccine 95.8% effective against COVID-19: Israel Health Ministry

The risk of illness from COVID-19 dropped 95.8 percent among people who received both shots of Pfizer's vaccine, Israel Health Ministry said.

Pfizer promises to double supply as Joe Biden pushes for quicker vaccine rollout

The drugmaker's chief executive, Albert Bourla, used a visit by the U.S. president to the company's largest manufacturing facility to announce that he expects to more than double the around 5 million doses per week the company currently provides to the U.S. government.

Pfizer submits data showing COVID-19 vaccine's stability in refrigerators

Pfizer/BioNTech’s vaccine, along with Moderna Inc’s two-dose vaccine, won the U.S. emergency use authorization (EUA) and is being widely distributed as part of the country’s mass vaccination efforts.

Joe Biden to visit Pfizer factory as Americans clamor for more COVID-19 vaccine supply

Biden is due to tour Pfizer's largest manufacturing site and its only facility in the United States making the COVID-19 vaccine at a time when less than 15% of the U.S. population is vaccinated.

Single dose of Pfizer COVID-19 vaccine provokes strong immune response: Study

Researchers from Bar-Ilan University and Ziv Medical Center in Israel noted that the real-world evidence with regard to the COVID-19 vaccine remains scarce even though the clinical trial data are encouraging.

Pfizer vaccine can neutralise coronavirus variants first reported in UK, South Africa: Study

The research, published in the journal Nature Medicine, noted that the vaccine is effective against coronavirus variants carrying the N501Y and E484K mutations.

Pfizer Q3 net profit up 1.56% at Rs 141 crore

The company had posted a net profit of Rs 139.06 crore for the corresponding period of the previous fiscal, Pfizer said in a filing to BSE.

Pfizer Standalone December 2020 Net Sales at Rs 593.49 crore, up 10.28% Y-o-Y

Pfizer withdraws application for emergency use of its COVID-19 vaccine in India

The U.S. company, which was the first drugmaker to apply for emergency use authorization of its COVID-19 vaccine in the country, had a meeting with India's drugs regulator on Wednesday and the decision was made after that, the company said.

India to get 97.2 million doses of COVID-19 vaccine from COVAX in first half of 2021

COVAX will be getting 240 million doses of AstraZeneca-Oxford University COVID-19 vaccine from SII and 96 million doses from AstraZeneca under the advance purchase agreement between Gavi and the vaccine makers. SII has agreed to supply COVID-19 vaccine at $3 per dose.

Australia allows Pfizer vaccine for all ages

Australia’s Therapeutic Goods Administration said in a statement Tuesday that it received reports on January 14 of about 30 deaths in more than 40,000 elderly people vaccinated with Pfizer. But it added that no causal link between vaccination and deaths could be established.

Pfizer sees about $15 billion in 2021 sales from COVID-19 vaccine

The company said it expects total 2021 revenue of between $59.4 billion and $61.4 billion.

COVID-19 Vaccine update | EU pressures AstraZeneca to deliver vaccines as promised

AstraZeneca's announcement that it will deliver fewer vaccines to the EU early on has only increased pressure on the 27-nation bloc, especially since Pfizer-BioNTech, the first vaccine to get EU approval, failed last week to keep up its promised deliveries to the EU.

COVID-19 vaccine update | Pfizer wants India to order coronavirus vaccine before pursuing approval

India's CDSCO says Pfizer officials failed to turn up to meetings after the company's application was made in early December. The regulator has also declined to accept the company's request for approval without a small local trial on the vaccine's safety and immunogenicity for Indians

WHO says Pfizer deal could allow poor countries to start vaccinating in February

US President Joe Biden's chief medical adviser Anthony Fauci said on Thursday the United States intended to join the facility.

Pfizer-BioNTech vaccine appears effective against UK COVID-19 strain: Study

The research team led by BioNTech Chief Executive Officer Ugur Sahin has said the result of the study proves it is very unlikely that the UK variant viruses will be able to dodge the Pfizer COVID-19 vaccine.

Pfizer reassures Europe over COVID-19 vaccines as pandemic surges

Worries have grown that delays in the delivery of Pfizer-BioNTech shots could hamper a European COVID-19 vaccine rollout which has already faced heavy criticism across the continent.

Vaccine rollout delayed in Europe as global COVID deaths near 2 million

At the Meissen crematorium in Germany's Saxony state, coffins were stacked up to three high, or even stored in hallways, awaiting cremation.

India wants Pfizer to do local study for approval: Official

Serum Institute of India, the local manufacturer of the vaccine developed by AstraZeneca Plc and Oxford University, has done a similar study on more than 1,500 people over months before seeking and receiving emergency approval in the country.